|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of KalVista Pharmaceuticals (NASDAQ: KALV) through any online brokerage.
The latest price target for KalVista Pharmaceuticals (NASDAQ: KALV) was reported by Roth Capital on 2021-02-18. The analyst firm set a price target for 55.00 expecting KALV to rise to within 12 months (a possible 118.08% upside). 6 analyst firms have reported ratings in the last year.
The stock price for KalVista Pharmaceuticals (NASDAQ: KALV) is $25.22 last updated Fri May 07 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for KalVista Pharmaceuticals.
There is no upcoming split for KalVista Pharmaceuticals.